Wells Fargo Maintains Overweight on Inspire Medical Systems, Raises Price Target to $330
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Inspire Medical Systems (NYSE:INSP) and raised the price target from $315 to $330.
August 04, 2023 | 11:14 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Inspire Medical Systems' price target has been raised from $315 to $330 by Wells Fargo, maintaining an Overweight rating.
The increase in price target by a reputable financial institution like Wells Fargo indicates a positive outlook for the company. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100